Asthma Research for Adolescents and Adults

Last updated: March 23, 2022
Sponsor: Astra Zeneca / VATHOS
Overall Status: Active - Recruiting

Phase

3

Condition

Asthma

Treatment

N/A

Clinical Study ID

TX295186
D5982C00006
  • Ages 12-80
  • All Genders

Study Summary

North Carolina Clinical Research is enrolling adults and adolescents with asthma in a clinical research study. All subjects will receive an active inhaler to treat their asthma.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Are 12 - 80 years of age
  • Have a documented history of asthma for greater than 6 months
  • Currently using a daily inhaler
  • Are a non-smoker with limited smoking history
  • Can attend 8 study morning visits at clinic (and additional 2 telemedicine visits) over approximately 6 months.
  • Additional criteria may apply

Exclusion

Exclusion Criteria:

  • Contact site for this criteria

Study Design

Study Start date:
October 12, 2021
Estimated Completion Date:
October 12, 2023

Study Description

Qualified participants will receive investigational drug and study-related care. If you qualify, you may be provided compensation for your time and travel.

Connect with a study center

  • North Carolina Clinical Research

    Raleigh, North Carolina 27607
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.